In addition to interviewing Dr Julien Edeline about the virtual ASCO Gastrointestinal Cancers Symposium (15-17 January 2021), Dr Rachel Giles presents interesting topics covered at the conference:
- FIGHT trial update: Bemarituzumab in gastric/GEJ cancers - Wainberg et al
- Frontline pembrolizumab in MSI-H/dMMR mCRC KEYNOTE 177 - Shiu et al
- Early promising efficacy of dostarlimab in advanced solid cancers - André et al
- Landmark OS for liver cancer, updated IMbrave150 - Finn et al
- Ivosidenib improves OS in IDH1-mutant cholangiocarcinoma - Zhu et al
- Nacre: Short-course radiotherapy with delayed surgery better for elderly rectal cancer patients - Francois et al
- Medicom interviews Dr Julien Edeline, medical oncologist at Centre Eugène Marquis, University of Rennes, France
Posted on
Previous Article
« No survival benefit for olaparib in BRCA-mutated metastatic pancreatic cancer Next Article
Borderline resectable pancreatic cancer: phase 2 results »
« No survival benefit for olaparib in BRCA-mutated metastatic pancreatic cancer Next Article
Borderline resectable pancreatic cancer: phase 2 results »
Related Articles
March 12, 2021
Gut microbiome DELIVERs nivolumab forecast in gastric cancer
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com